Zhi-Ming Shao, Jihui Hao, Shui Wang, Qingyuan Zhang, Yuanting Gu, Fuguo Tian, Shouman Wang, Quchang Ouyang, Longzhen Zhang, Yunjiang Liu, Jing Cheng, Shundong Cang, Zhenzhen Liu, Chunsen Xu, Jianyun Nie, Ye Lv, Jun Qian, Ting Wang, Mengzhu Yu, Fei Wu. "Dalpiciclib (Dalp) plus endocrine therapy (ET) as adjuvant treatment for HR+/HER2– early breast cancer (BC): The randomized, phase 3, DAWNA-A trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.515